Trident Texofab announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 November 2024 .Powered by Capital Market - Live News

Net profit of Trident Texofab rose 33.33% to Rs 1.00 crore in the quarter ended September 2024 as against Rs 0.75 crore during the previous quarter ended September 2023. Sales rose 14.01% to Rs 26.45 crore in the quarter ended September 2024 as against Rs 23.20 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales26.4523.20 14 OPM %-1.065.43 - PBDT1.351.22 11 PBT0.940.81 16 NP1.000.75 33 Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 12 October 2024.Powered by Capital Market - Live News

Trident Texofab announced that the 16th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live News

Net profit of Trident Texofab reported to Rs 0.70 crore in the quarter ended June 2024 as against net loss of Rs 0.13 crore during the previous quarter ended June 2023. Sales rose 11.30% to Rs 25.71 crore in the quarter ended June 2024 as against Rs 23.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales25.7123.10 11 OPM %5.956.19 - PBDT1.340.27 396 PBT0.93-0.14 LP NP0.70-0.13 LP Powered by Capital Market - Live News